Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bierman

Showing results (181-190 of 253) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's diseaseP J Bierman, J M Vose, P K Leichner, et al.
American Journal of Hematology|June 22, 2000
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study GroupD D Weisenburger, J M Vose, T C Greiner, et al.
American Journal of Hematology|March 30, 2005
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantationSteven Z Pavletic, Lynette M Smith, Michael R Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
JAMA|October 25, 1995
Multiple organ dysfunction syndrome in bone marrow transplantationW D Haire, E I Ruby, B G Gordon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantationW D Haire, E I Ruby, L C Stephens, et al.
Bone Marrow Transplantation|December 1, 1991
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapyW P Vaughan, J D Dennison, E C Reed, et al.
Leukemia & Lymphoma|September 18, 2015
Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group ExperienceVijaya R Bhatt, Fausto R Loberiza, Lynette M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Pageof 26

Showing results (181-190 of 253) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's diseaseP J Bierman, J M Vose, P K Leichner, et al.
American Journal of Hematology|June 22, 2000
Mantle cell lymphoma. A clinicopathologic study of 68 cases from the Nebraska Lymphoma Study GroupD D Weisenburger, J M Vose, T C Greiner, et al.
American Journal of Hematology|March 30, 2005
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantationSteven Z Pavletic, Lynette M Smith, Michael R Bishop, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1996
Phase I trial of recombinant fusion protein PIXY321 for mobilization of peripheral-blood cellsM R Bishop, J D Jackson, B O'Kane-Murphy, et al.
Journal of Hematotherapy|April 1, 1995
Comparison of subcutaneous and intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor for peripheral blood stem cell mobilizationA Kessinger, M R Bishop, J R Anderson, et al.
JAMA|October 25, 1995
Multiple organ dysfunction syndrome in bone marrow transplantationW D Haire, E I Ruby, B G Gordon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 29, 1999
A prospective randomized double-blind trial of antithrombin III concentrate in the treatment of multiple-organ dysfunction syndrome during hematopoietic stem cell transplantationW D Haire, E I Ruby, L C Stephens, et al.
Bone Marrow Transplantation|December 1, 1991
Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapyW P Vaughan, J D Dennison, E C Reed, et al.
Leukemia & Lymphoma|September 18, 2015
Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group ExperienceVijaya R Bhatt, Fausto R Loberiza, Lynette M Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2003
Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationPhilip J Bierman, John W Sweetenham, Fausto R Loberiza, et al.
Pageof 26